Logos Global Management LP - Nov 14, 2025 SCHEDULE 13D/A Report for Design Therapeutics, Inc. Common Stock (DSGN)

Filing Manager
Logos Global Management LP
Reporting Manager
Arsani William
Security
Design Therapeutics, Inc. Common Stock
Symbol
DSGN
Shares outstanding
57.2M shares
Disclosed Ownership
2.52M shares
Ownership
4.4%
Form type
SCHEDULE 13D/A
Date filed
11/18/2025, 05:57 PM
Date of event
Nov 14, 2025
Previous filing
Nov 12, 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Logos Global Management LP 4.4% 2.5M 0 2.5M /s/ Arsani William Managing Partner 0001792126
Logos Global Management GP LLC 4.4% 2.5M 0 2.5M /s/ Arsani William Managing Member
Logos Global Master Fund LP 2.6% 1.5M 0 1.5M /s/ Arsani William Managing Member of Logos GP LLC, General Partner of Logos Global Master Fund LP 0001831371
Logos GP LLC 2.6% 1.5M 0 1.5M /s/ Arsani William Managing Member
Arsani William 4.4% 2.52M 15K 2.5M /s/ Arsani William Self Reporting 0001848372